New clinical practice guidelines address anticoagulation during cardiopulmonary bypass
Editor's Note
The Society of Thoracic Surgeons, Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology on January 19 announced the release of new clinical practice guidelines on the use of anticoagulants during cardiopulmonary bypass (CPB).
Among the guideline recommendations are:
- optimal heparin dosing for initiation and maintenance of CPB
- identifying contraindications for use of heparin
- providing options for alternatives to heparin
- ideal methods for reversal of anticoagulation after CPB.
The goal of the guidelines is for more standardization in practice and to help clinicians practice consistent and safe coagulation, the authors say.
Leading societies release first comprehensive guideline of its kind CHICAGO (January 19, 2018) - The Society of Thoracic Surgeons (STS), the Society of Cardiovascular Anesthesiologists (SCA), and the American Society of ExtraCorporeal Technology (AmSECT) released a new clinical practice guideline that includes major recommendations for the use of blood thinning medication (anticoagulants) during heart surgery.
Free Daily News
- Study: COVID-19's impact on oncological surgery offers lessons for future crises
- Study links pandemic stress to persistent increases in nursing-sensitive quality indicators
- Save the date for the 2025 OR Business Management Conference
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO